Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Superior Results Of The Comparative Study Of The Company's Recombinant Two-Component COVID-19 Vaccine ReCOV As Compared To International Mainstream mRNA Vaccine 2022-12-14 15:17
Sirnaomics Executive Director Dr. Xiaochang Dai to Deliver Keynote Speech at BIOHK2022 2022-12-14 01:41
Treadwell Therapeutics Announces A Presentation at the 2022 ASH Annual Meeting Featuring a Clinical Trial Update on CFI-400945, an oral PLK4 inhibitor 2022-12-13 22:30
VeriSIM Life Earns Frost & Sullivan Competitive Strategy Leadership Award for Best Practices in AI-enabled Preclinical Development Industry 2022-12-13 21:00
RemeGen's RC118 for Injection Targeting Claudin 18.2 in Patients with Gastric and Pancreatic Cancers Granted Two Orphan Drug Designations by U.S. FDA 2022-12-13 12:30
CSL Announces Next CEO & Managing Director 2022-12-13 07:23
Ascletis Announces Positive Phase I Clinical Results of Oral RdRp Inhibitor ASC10 for COVID-19 2022-12-12 23:29
JW Therapeutics Presents Latest Clinical Data on Carteyva® in Follicular Lymphoma and Mantle Cell Lymphoma at the 64th ASH Annual Meeting 2022-12-12 18:00
Goodwin Biotechnology Inc. is now GBI, as Part of their Rebranding Initiative on their 30-Year Anniversary! 2022-12-10 04:16
Treadwell Therapeutics Announces A Presentation at the 2022 SABCS Annual Meeting Featuring a Clinical Trial Update on CFI-402257, a Best-in-Class TTK inhibitor 2022-12-09 22:30
Antengene Announces HREC Approval in Australia for the Phase I Trial of ATG-022 (Claudin 18.2 ADC) in Patients with Advanced or Metastatic Solid Tumors 2022-12-09 08:30
PGTG successfully develops SGF bone-derived factor to restore the skeletal system 2022-12-07 12:00
Turn Biotechnologies Changes Paradigm in Skin Rejuvenation 2022-12-06 22:00
GenScript ProBio Congratulates Selecxine's IND Clearance from MFDS 2022-12-06 17:14
University of Tokyo and Sekisui House Launch Joint Research on Biodiversity and Health 2022-12-06 14:00
Telix Announces Executive Leadership Appointments 2022-12-05 06:39
FOUNDATION FOR ANGELMAN SYNDROME THERAPEUTICS (FAST) ANNOUNCES $5 MILLION GIFT TO ADVANCE CLINICAL TRIALS IN RARE NEURODEVELOPMENTAL DISORDERS 2022-12-03 01:07
Sirolimus Coated Balloon in BTK Treatment makes a bold presence at VEITH 2022 - Lights up NY Times Square, NASDAQ 2022-12-02 21:10
Focus-X Therapeutics, a Viva Biotech Portfolio Company, Successfully Reached an Acquisition Agreement with Full-Life Technologies 2022-12-02 18:23
CUVET Successfully Developed the First Stem Cell Transplantation Technology to Treat Pet Diabetes 2022-12-02 10:00
1 51 52 53 54 55 211